Tobramycin therapy of pulmonary infections in patients with cystic fibrosis

Curr Ther Res Clin Exp. 1974 May;16(5):414-23.
No abstract available

MeSH terms

  • Aminoglycosides / analysis
  • Aminoglycosides / blood
  • Aminoglycosides / pharmacology
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / analysis
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Cystic Fibrosis / complications*
  • Humans
  • Lung Diseases / drug therapy*
  • Lung Diseases / etiology
  • Lung Diseases / microbiology
  • Pseudomonas / drug effects
  • Pseudomonas / isolation & purification
  • Pseudomonas Infections / drug therapy*
  • Sputum / analysis
  • Sputum / microbiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus / drug effects
  • Staphylococcus / isolation & purification

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents